A 2017 Cochrane review reported effect estimates that approached significance for the outcome of less death or BPD with iNO over placebo in preterm infants and recommended further study [ 35 ], however the subsequent NEWNO trial found no benefit on survival without BPD or neurodevelopmental outcomes [ 34 ].
← all excerpts
Pulmonary vasodilator use in very preterm infants in United States children's hospitals.
1
—
—